MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 157 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $13,688,000 | +6.5% | 411,436 | -12.9% | 0.39% | -15.6% |
Q1 2020 | $12,853,000 | -13.2% | 472,546 | -37.0% | 0.46% | +22.3% |
Q4 2019 | $14,810,000 | +37.2% | 750,633 | -9.8% | 0.38% | +28.2% |
Q3 2019 | $10,791,000 | +7.6% | 832,627 | +3.4% | 0.29% | +19.0% |
Q2 2019 | $10,025,000 | – | 805,250 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NORTH TIDE CAPITAL, LLC | 2,500,000 | $28,350,000 | 2.16% |
SENZAR ASSET MANAGEMENT, LLC | 454,600 | $5,155,000 | 1.51% |
Palo Alto Investors LP | 1,455,176 | $16,502,000 | 1.23% |
SECTORAL ASSET MANAGEMENT INC | 2,134,440 | $24,205,000 | 1.02% |
AlphaMark Advisors, LLC | 130,699 | $1,482,000 | 0.94% |
Cheyne Capital Management (UK) LLP | 172,353 | $1,955,000 | 0.70% |
Regal Investment Advisors LLC | 183,972 | $2,086,000 | 0.63% |
Tekla Capital Management LLC | 1,067,575 | $12,106,000 | 0.57% |
March Altus Capital Management LP | 103,729 | $1,176,000 | 0.47% |
CAPITAL MANAGEMENT ASSOCIATES /NY/ | 19,500 | $221,000 | 0.33% |